Corneal Substructure Dosimetry Predicts Corneal Toxicity in Patients with Uveal Melanoma Treated with Proton Beam Therapy

Glaucoma and Ocular PressureOcular Oncology

Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects

Graefes Arch Clin Exp Ophthalmol.

Riechardt AI, Klein JP, Cordini D, Heufelder J, Rehak M, Seibel I, Joussen AM

doi: 10.1007/s00417-018-3929-5.

Ocular Oncology

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition

Eur J Cancer.

Heppt MV, Heinzerling L, Kähler KC, Forschner A, Kirchberger MC, Loquai C, Meissner M, Meier F, Terheyden P, Schell B, Herbst R, Göppner D, Kiecker F, Rafei-Shamsabadi D, Haferkamp S, Huber MA, Utikal J, Ziemer M, Bumeder I, Pfeiffer C, Schäd SG, Schmid-Tannwald C, Tietze JK, Eigentler TK, Berking C

doi: 10.1016/j.ejca.2017.05.038.

Ocular Oncology

Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D

Ophthalmology.

Vichitvejpaisal P, Dalvin LA, Mazloumi M, Ewens KG, Ganguly A, Shields CL

doi: 10.1016/j.ophtha.2019.04.027.

Ocular Oncology

Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients

Invest Ophthalmol Vis Sci.

Drabarek W, Yavuzyigitoglu S, Obulkasim A, van Riet J, Smit KN, van Poppelen NM, Vaarwater J, Brands T, Eussen B, Verdijk RM, Naus NC, Mensink HW, Paridaens D, Boersma E, van de Werken HJG, Kilic E, de Klein A, for the Rotterdam Ocular Melanoma Study Group.

doi: 10.1167/iovs.18-24818.

Macular DiseasesOcular Oncology

Occurrence of phosphenes in patients undergoing proton beam therapy for ocular tumor

Am J Ophthalmol.

Mathis T, Hofverberg P, Caujolle JP, Hérault J, Leal C, Maschi C, Delaunay B, Baillif S, Kodjikian L, Thariat J

doi: 10.1016/

Ocular Oncology

Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis

Br J Ophthalmol.

Thornton S, Coupland SE, Heimann H, Hussain R, Groenewald C, Kacperek A, Damato B, Taktak A, Eleuteri A, Kalirai H

doi: 10.1136/bjophthalmol-2019-315363.

Ocular Oncology

A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes

Br J Ophthalmol.

Binkley E, Triozzi PL, Rybicki L, Achberger S, Aldrich W, Singh A

doi: 10.1136/bjophthalmol-2019-314461.

Ocular Oncology

Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanomas

Ophthalmology.

Espensen CA, Kiilgaard JF, Appelt AL, Fog LS, Herault J, Maschi C, Caujolle JP, Thariat J

doi: 10.1016/j.ophtha.2020.06.030.

Cataracts

The Lens Opacities Classification System III grading in irradiated uveal melanomas to characterize proton induced cataracts

Am J Ophthalmol.

Mathis T, Rosier L, Meniai F, Baillif S, Maschi C, Herault J, Caujolle JP, Kodjikian L, Salleron J, Thariat J

doi: 10.1016/j.ajo.2019.01.025.

Related content

Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition

Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D

Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients

Occurrence of phosphenes in patients undergoing proton beam therapy for ocular tumor

Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis

A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes

Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanomas

The Lens Opacities Classification System III grading in irradiated uveal melanomas to characterize proton induced cataracts